Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mark Houser"'
Autor:
Steven Fishbane, Carol A. Pollock, Mohamed El-Shahawy, Elizabeth T. Escudero, Anjay Rastogi, Bui Pham Van, Lars Frison, Mark Houser, Maksym Pola, Dustin J. Little, Nicolas Guzman, Pablo E. Pergola
Publikováno v:
Journal of the American Society of Nephrology. 33:850-866
Autor:
Blai Coll, Mark Houser, Dennis Andress, Dick de Zeeuw, Pablo E. Pergola, Yili Pritchett, Donald E. Kohan, Hirofumi Makino, Sheldon W. Tobe, Hiddo J.L. Heerspink, Hans-Henrik Parving, Robert S. Busch, Ricardo Correa-Rotter, Vlado Perkovic, John J. Brennan, Robert D. Toto, Giuseppe Remuzzi, David J. Webb
Publikováno v:
Webb, D J, Coll, B, Heerspink, H J L, Andress, D, Pritchett, Y, Brennan, J J, Houser, M, Correa-Rotter, R, Kohan, D, Makino, H, Perkovic, V, Remuzzi, G, Tobe, S W, Toto, R, Busch, R, Pergola, P, Parving, H-H & de Zeeuw, D 2017, ' Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy : A Randomized, Double-Blind, Placebo-Controlled Trial ', Drugs, pp. 441-448 . https://doi.org/10.1007/s40268-017-0201-0
Drugs in R&D, 17(3), 441-448
Drugs in R&D
Drugs in R&D, 17(3), 441-448
Drugs in R&D
BACKGROUND: Fluid retention is a common adverse event in patients who receive endothelin (ET) receptor antagonist therapy, including the highly selective ETA receptor antagonist, atrasentan.OBJECTIVE: We performed longitudinal assessments of thoracic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c6fc266a8c2e6a85c8f83451f4d65c3
https://www.pure.ed.ac.uk/ws/files/43186284/10.1007_s40268_017_0201_0.pdf
https://www.pure.ed.ac.uk/ws/files/43186284/10.1007_s40268_017_0201_0.pdf
Autor:
Ann Eldred, Bruce A. Molitoris, Samina Khan, Ravindra L. Mehta, Greg Ball, Lakhmir S. Chawla, Ho Jin Lee, Elliott Bennett-Guerrero, Mark Houser, Peter A. McCullough, Thomas M. Beaver
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Patients undergoing cardiac surgeries with cardiopulmonary bypass (on‐pump) have a high risk for acute kidney injury ( AKI ). We tested ABT ‐719, a novel α‐melanocyte‐stimulating hormone analog, for prevention of AKI in postoperat
Autor:
Hirofumi Makino, Giancarlo Viberti, Donald E. Kohan, Dick de Zeeuw, Yili Pritchett, Dennis L. Andress, Hans-Henrik Parving, Giuseppe Remuzzi, Mark Houser, John J. Brennan, Blai Coll, Hiddo J.L. Heerspink, Sheldon W. Tobe, Ricardo Correa-Rotter, Robert D. Toto, Vlado Perkovic, Hui Tang
Publikováno v:
Journal of the American Society of Nephrology, 25(5), 1083-1093. AMER SOC NEPHROLOGY
Despite optimal treatment, including renin-angiotensin system (RAS) inhibitors, patients with type 2 diabetic nephropathy have high cardiorenal morbidity and mortality related to residual albuminuria. We evaluated whether or not atrasentan, a selecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5f4fd170edc17e0f32ee66ed6f849d6
https://research.rug.nl/en/publications/6ce31002-ea4d-4145-af65-0be5d4bfd208
https://research.rug.nl/en/publications/6ce31002-ea4d-4145-af65-0be5d4bfd208
Publikováno v:
American Journal of Kidney Diseases. 3:219-223
Following multiple technical problems with Tenckhoff catheters in children commencing prolonged dwell peritoneal dialysis, we have recently used the Toronto Western Hospital (TWH) catheter with considerable success. Six of the TWH catheters were inse
Publikováno v:
Toxicological Sciences. 5:832-839
Publikováno v:
Fundamental and Applied Toxicology. 5:832-839
The kidney is well documented as the target organ for mercuric ion. Mechanisms by which this ion accumulates in renal tissue, however, are less well understood. Sulfhydryl groups in renal tissue might well bind this metal and serve as a sink for its